India’s expert committee on Covid-19 vaccines has sought more data from Hyderabad-based Biological E to review its request for marketing authorisation of its Covid-19 vaccine Corbevax for use in children aged 5 to 12 years, people in the know said. They said the DCGI’s subject expert committee reviewed Biological E’s application at a meeting on…Continue Reading
HYDERABAD: Biological E Limited (BE), the Hyderabad-based vaccine maker that has developed a recombinant sub-unit protein vaccine Corbevax for Covid-19, has now been selected as a recipient of mRNA technology from the World Health Organisation (WHO)’s technology transfer hub. BE was selected by WHO’s Advisory Committee on Vaccine Product Development (ACPDV) as a recipient of…Continue Reading
Biological E Ltd, a Hyderabad-based pharmaceutical business, announced on Monday that its coronavirus vaccine, Corbevax, has acquired emergency use approval in India for children aged 12 to 18. Corbevax is India’s third homegrown vaccine. The Drug Controller General of India (DCGI), Dr. V. G. Somani, granted the approval for Corbevax. So far, only children aged…Continue Reading
People wait in a queue to receive the vaccine against coronavirus disease (COVID-19) outside a shopping mall in Mumbai, India, August 11, 2021. REUTERS/Francis MascarenhasRegister now for FREE unlimited access to Reuters.comBENGALURU, Feb 21 (Reuters) – Indian vaccine maker Biological E. Ltd said on Monday its COVID-19 vaccine received an emergency use approval in the…Continue Reading
SynopsisBiological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the city-based company to deliver 300 Million doses as promised to the Centre, the company said.TOI-OnlineCorbevax has completed two Phase III…Continue Reading
Pharma major Biological E has sought approval from drug regulator Drugs Controller General of India to conduct the phase-3 clinical trial of Covid vaccine Corbevax. The company has sought approval as a single booster dose for those fully vaccinated with Covishield or Covaxin vaccines.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard…Continue Reading